Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …

BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2024 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …

Allopurinol hypersensitivity: a systematic review of all published cases, 1950–2012

SN Ramasamy, CS Korb-Wells, DRW Kannangara… - Drug safety, 2013 - Springer
Background Allopurinol is the primary therapy for the management of chronic gout.
Utilization of allopurinol has increased in tandem with the growing prevalence of gout …

HLA-A* 3101 and carbamazepine-induced hypersensitivity reactions in Europeans

M McCormack, A Alfirevic, S Bourgeois… - … England Journal of …, 2011 - Mass Medical Soc
Background Carbamazepine causes various forms of hypersensitivity reactions, ranging
from maculopapular exanthema to severe blistering reactions. The HLA-B* 1502 allele has …

Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

EY Lee, C Knox, EJ Phillips - JAMA dermatology, 2023 - jamanetwork.com
Importance Antibiotics are an important risk for Stevens-Johnson syndrome and toxic
epidermal necrolysis (SJS/TEN), which are the most severe types of drug hypersensitivity …

Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan

CY Yang, CH Chen, ST Deng, CS Huang… - JAMA internal …, 2015 - jamanetwork.com
Importance Allopurinol, a first-line drug used for treating gout, is increasingly prescribed
worldwide to patients with asymptomatic hyperuricemia and comorbid renal or …

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module

AR Wolfson, L Zhou, Y Li, NA Phadke, OA Chow… - The Journal of Allergy …, 2019 - Elsevier
Background Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is
a rare but severe hypersensitivity reaction that remains poorly characterized in the United …

Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice

JG Peter, R Lehloenya, S Dlamini, K Risma… - The Journal of Allergy …, 2017 - Elsevier
Most immune-mediated adverse drug reactions (IM-ADRs) involve the skin, and many have
additional systemic features. Severe cutaneous adverse drug reactions (SCARs) are an …

Personalized pharmacogenomics: predicting efficacy and adverse drug reactions

M Pirmohamed - Annual review of genomics and human …, 2014 - annualreviews.org
Drug response varies between individuals owing to disease heterogeneity, environmental
factors, and genetic factors. Genetic factors can affect both the pharmacokinetics and …

[HTML][HTML] New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity

M Pirmohamed, DA Ostrov, BK Park - Journal of Allergy and Clinical …, 2015 - Elsevier
Drug hypersensitivity reactions are an important clinical problem for both health care and
industry. Recent advances in genetics have identified a number of HLA alleles associated …

Cutaneous adverse drug reactions in Indian population: A systematic review

TK Patel, SH Thakkar, DC Sharma - Indian dermatology online …, 2014 - journals.lww.com
Background: Epidemiological data is limited for cutaneous adverse drug reactions (CADRs)
in India. Most of the Indian studies have small sample size and are of limited duration. Aims …